Publications by authors named "M Kalafat"

Patients with Alzheimer's disease (AD) suffer from various types of memory distortions. We showed that confabulations are plausible memories, mainly reflecting the recall of repeated personal events mistakenly considered by confabulating patients as specific and unique events. The aim of this study is to see whether the notion that over-learned information interferes in episodic memory recall, as it does in confabulation, can be extended to another type of memory distortion, namely false recognition (i.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how cancer cells interact with their extracellular matrix (ECM) and focuses on the role of keratin in cellular movement and spreading.
  • Keratin phosphorylation combined with actin inhibition was found to significantly reduce the area of Panc-1 pancreatic cancer cells compared to either treatment alone.
  • By altering the keratin structure and using various ECM environments, the researchers demonstrated that these changes enhanced the cells' mobility and directed migration, emphasizing the importance of both internal and external cell structures in cancer progression.
View Article and Find Full Text PDF

With the prospect of disease-modifying drugs that will target the physiopathological process of Alzheimer's disease, it is now crucial to increase the understanding of the atypical focal presentations of Alzheimer's disease, such as posterior cortical atrophy. This study aimed to (i) characterize the brain perfusion profile in posterior cortical atrophy using regions of interest and a voxel-based approach; (ii) study the influence of the disease duration on the clinical and imaging profiles; and (iii) explore the correlations between brain perfusion and cognitive deficits. Thirty-nine patients with posterior cortical atrophy underwent a specific battery of neuropsychological tests, mainly targeting visuospatial functions, and a brain perfusion scintigraphy with 99mTc-ethyl cysteinate dimer.

View Article and Find Full Text PDF

Current treatments for Alzheimer's disease aim to compensate for biochemical deficits in the brain. They are purely symptomatic and restore the central cholinergic deficit. Acetylcholinesterase inhibitors have modest but significant efficacy on cognitive disorders, activities of daily living, and the global clinical impression.

View Article and Find Full Text PDF